UK firm GSK to pay $2.2bn over Zantac cancer claimsGSK is settling $2.2bn over Zantac cancer claims, resolving 93% of lawsuits without admitting wrongdoing.
British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuitsGSK reported a £58 million loss due to Zantac settlement, contrasting with a £1.5 billion profit last year.
British pharma giant GSK strikes $2.3 billion deal to put an end to 80,000 U.S. lawsuitsGSK has agreed to pay $2.3 billion to settle lawsuits over Zantac's alleged cancer risk, while denying any liability.
UK firm GSK to pay $2.2bn over Zantac cancer claimsGSK is settling $2.2bn over Zantac cancer claims, resolving 93% of lawsuits without admitting wrongdoing.
British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuitsGSK reported a £58 million loss due to Zantac settlement, contrasting with a £1.5 billion profit last year.
British pharma giant GSK strikes $2.3 billion deal to put an end to 80,000 U.S. lawsuitsGSK has agreed to pay $2.3 billion to settle lawsuits over Zantac's alleged cancer risk, while denying any liability.